Literature DB >> 9700555

Testing for drugs of abuse in saliva and sweat.

D A Kidwell1, J C Holland, S Athanaselis.   

Abstract

The detection of marijuana, cocaine, opiates, amphetamines, benzodiazepines, barbiturates, PCP, alcohol and nicotine in saliva and sweat is reviewed, with emphasis on forensic applications. The short window of detection and lower levels of drugs present compared to levels found in urine limits the applications of sweat and saliva screening for drug use determination. However, these matrices may be applicable for use in driving while intoxicated and surveying populations for illicit drug use. Although not an illicit drug, the detection of ethanol is reviewed because of its importance in driving under the influence. Only with alcohol may saliva be used to estimate blood levels and the degree of impairment because of the problems with oral contamination and drug concentrations varying depending upon how the saliva is obtained. The detection of nicotine and cotinine (from smoking tobacco) is also covered because of its use in life insurance screening and surveying for passive exposure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700555     DOI: 10.1016/s0378-4347(97)00572-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  21 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.

Authors:  Bettina Link; Manuel Haschke; Nathalie Grignaschi; Michael Bodmer; Yvonne Zysset Aschmann; Markus Wenk; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

3.  The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications.

Authors:  Z Sonner; E Wilder; J Heikenfeld; G Kasting; F Beyette; D Swaile; F Sherman; J Joyce; J Hagen; N Kelley-Loughnane; R Naik
Journal:  Biomicrofluidics       Date:  2015-05-15       Impact factor: 2.800

4.  Sampling of disease biomarkers from skin for theranostic applications.

Authors:  Makoto Ogura; Sumit Paliwal; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

5.  Pharmacokinetics study of mazindol in plasma, oral fluid, and urine of volunteers.

Authors:  Marcella Herbstrith de Oliveira; Pâmela Cristina Lukasewicz Ferreira; Graciela Carlos; Fernanda Rodrigues Salazar; Ana Maria Bergold; Flavio Pechansky; Renata Pereira Limberger; Pedro Eduardo Fröehlich
Journal:  Eur J Clin Pharmacol       Date:  2016-04-12       Impact factor: 2.953

6.  Using Sesame Seed Oil to Preserve and Preconcentrate Cannabinoids for Paper Spray Mass Spectrometry.

Authors:  Brandon Bills; Nicholas Manicke
Journal:  J Am Soc Mass Spectrom       Date:  2020-01-27       Impact factor: 3.109

Review 7.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 8.  Saliva: an emerging biofluid for early detection of diseases.

Authors:  Yu-Hsiang Lee; David T Wong
Journal:  Am J Dent       Date:  2009-08       Impact factor: 1.522

9.  Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat.

Authors:  Bruno S De Martinis; Allan J Barnes; Karl B Scheidweiler; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

10.  Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients.

Authors:  Courtney D Nordeck; Jan Gryczynski; Kevin E O'Grady; Kathryn Polak; Dace S Svikis; Jennifer McNeely; Li-Tzy Wu; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2020-02-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.